Description
The debate identified gait changes as early biomarkers and motor cortex stimulation as promising therapy, but didn’t establish when in the disease progression such interventions would be most effective. This timing question is critical for clinical trial design.
Source: Debate session sess_sda-2026-04-01-gap-012 (Analysis: sda-2026-04-01-gap-012)